The Science Behind Calcifediol Monohydrate (CAS 63283-36-3)： What You Need to Know

Abstract

This article delves into the science behind Calcifediol Monohydrate (CAS 63283-36-3), a crucial compound in the field of bone health and vitamin D metabolism. It provides an overview of its structure, function, and applications, highlighting its role in calcium absorption and bone mineralization. The article also discusses the importance of understanding its pharmacokinetics, potential side effects, and the latest research findings. By exploring these aspects, the article aims to offer a comprehensive understanding of Calcifediol Monohydrate and its significance in healthcare.

Introduction to Calcifediol Monohydrate (CAS 63283-36-3)

Calcifediol Monohydrate, also known as vitamin D3, is a fat-soluble vitamin that plays a vital role in calcium absorption and bone mineralization. It is synthesized in the skin upon exposure to sunlight or obtained through dietary sources. This compound is crucial for maintaining healthy bones and teeth, as well as for regulating the immune system. In this article, we will explore the science behind Calcifediol Monohydrate, its structure, function, and applications, and the latest research findings.

Structure and Chemical Properties

Calcifediol Monohydrate is a white to off-white crystalline powder with a melting point of approximately 84-86°C. It has a molecular formula of C27H44O and a molecular weight of 396.65 g/mol. The compound consists of a sterol backbone with a 1α,25-dihydroxy group attached to the 1st carbon atom. This structure is similar to that of vitamin D3, which is synthesized in the skin upon exposure to sunlight. The monohydrate form of Calcifediol is obtained by crystallizing the compound from a solution containing water.

Function and Mechanism of Action

Calcifediol Monohydrate functions by activating the vitamin D receptor (VDR) in the nucleus of target cells. This activation leads to the transcription of specific genes involved in calcium absorption, bone mineralization, and immune regulation. The active form of vitamin D, calcitriol, is produced in the kidneys upon hydroxylation of Calcifediol. Calcitriol then binds to the VDR, resulting in the upregulation of calcium-binding proteins, such as calbindin-D, which facilitate calcium absorption in the intestines. Additionally, Calcifediol Monohydrate promotes the differentiation of osteoblasts, the cells responsible for bone formation, and inhibits the activity of osteoclasts, the cells that break down bone tissue.

Pharmacokinetics and Bioavailability

The pharmacokinetics of Calcifediol Monohydrate involve its absorption, distribution, metabolism, and excretion. After oral administration, the compound is absorbed in the small intestine and enters the bloodstream. It is then transported to the liver, where it is converted to calcifediol. Subsequently, calcifediol is hydroxylated in the kidneys to produce calcitriol, the active form of vitamin D. The bioavailability of Calcifediol Monohydrate can vary depending on factors such as age, dietary intake, and the presence of certain diseases. The half-life of calcifediol in the blood is approximately 3-5 days, while the half-life of calcitriol is shorter, around 6-12 hours.

Applications and Therapeutic Uses

Calcifediol Monohydrate is widely used in the treatment of vitamin D deficiency, which can lead to conditions such as rickets in children and osteomalacia in adults. It is also used to manage secondary hyperparathyroidism, a condition characterized by elevated levels of parathyroid hormone (PTH) due to chronic kidney disease or other factors. Additionally, Calcifediol Monohydrate is used in the prevention and treatment of osteoporosis, a condition characterized by weakened bones. The compound is often prescribed in combination with calcium supplements to enhance bone mineralization.

Potential Side Effects and Safety Concerns

While Calcifediol Monohydrate is generally safe and well-tolerated, it can cause certain side effects, particularly at high doses. These include hypercalcemia, a condition characterized by elevated levels of calcium in the blood, which can lead to symptoms such as nausea, vomiting, and kidney stones. Other potential side effects include hypercalciuria, increased calcium excretion in the urine, and an increased risk of cardiovascular events. It is important to monitor blood calcium levels and adjust the dose accordingly to minimize the risk of side effects.

Latest Research Findings

Recent research has focused on the role of Calcifediol Monohydrate in various diseases beyond bone health. Studies have shown that vitamin D may play a role in the prevention and treatment of certain types of cancer, such as breast, colon, and prostate cancer. Additionally, vitamin D has been found to have anti-inflammatory properties, which may be beneficial in the management of autoimmune diseases, such as multiple sclerosis and type 1 diabetes. Ongoing research continues to explore the potential therapeutic applications of Calcifediol Monohydrate in these and other conditions.

Conclusion

In conclusion, Calcifediol Monohydrate (CAS 63283-36-3) is a crucial compound in the field of bone health and vitamin D metabolism. Its structure, function, and applications have been extensively studied, and its role in calcium absorption and bone mineralization is well-established. Understanding the pharmacokinetics, potential side effects, and the latest research findings is essential for healthcare professionals and patients alike. As research continues to uncover new therapeutic applications of Calcifediol Monohydrate, its significance in healthcare is likely to grow.

Keywords: Calcifediol Monohydrate, vitamin D3, bone health, calcium absorption, bone mineralization, pharmacokinetics, side effects, research findings.